Neurock Pharmaceuticals
Princeton, US · Founded 2022 · Delaware corporation
Founders & leadership
HW
Haixing WangNamed on SEC filing
QW
Qingxi WangNamed on SEC filing
LC
Lei CaiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2024
▶$10MraisedMar 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$10MraisedMar 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Haixing WangExecutive Officer
- Qingxi WangDirector
- Lei CaiExecutive Officer
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Neurock Pharmaceuticals raised?
- Neurock Pharmaceuticals has disclosed $10M raised across 1 round.
- Where is Neurock Pharmaceuticals headquartered?
- Neurock Pharmaceuticals is headquartered in Princeton, US.